Search

Certara Inc

Cerrado

SectorSanidad

8.49 0.95

Resumen

Variación precio

24h

Actual

Mínimo

8.25

Máximo

8.44

Métricas clave

By Trading Economics

Ingresos

-380K

-9.1M

Ventas

-14M

93M

P/B

Media del Sector

100.714

56.432

BPA

0.05

Margen de beneficios

-9.803

Empleados

1,515

EBITDA

-4.2M

12M

Recomendaciones

By TipRanks

Recomendaciones

Neutral

Estimación a 12 Meses

-3.8% downside

Dividendos

By Acuity

Próximas Ganancias

5 nov 2026

Estadísticas de Mercado

By TradingEconomics

Capitalización Mercado

-52M

1.2B

Apertura anterior

7.54

Cierre anterior

8.49

Noticias sobre sentimiento de mercado

By Acuity

50%

50%

106 / 339 Clasificación en Healthcare

Certara Inc Gráfico

Resultados pasados no son un indicador fiable de resultados futuros.

Noticias Relacionadas

18 sept 2026, 20:07 UTC

Certara Inc's stock is declining, having pulled back from an earlier peak, and remains lower compared to Thursday's close while trading above its 20-day moving average.

17 sept 2026, 23:31 UTC

Certara Inc is rising in after-market trading, reaching a peak shortly after the market closed, significantly above its 20-day moving average.

16 sept 2026, 22:01 UTC

Certara Inc is seeing a slight uptick in after-market trading, recovering from a brief dip to achieve a modest gain within its one-month trading range.

15 sept 2026, 20:01 UTC

Certara Inc shares are higher during Tuesday's session, diverging from broader market sentiment impacted by a decline in the NY Empire State Manufacturing Index.

14 sept 2026, 19:51 UTC

Certara Inc shares are trading higher, continuing a recent upward trend. No specific news was identified to explain this price movement.

10 sept 2026, 20:07 UTC

Shares of Certara Inc. are trading lower today, reflecting broader market trends amid five consecutive sessions of declines and pressure from recent interest rate hikes.

9 sept 2026, 20:07 UTC

Certara Inc. shares are lower today, breaking the upward trend seen since Tuesday's close. No specific news or development was identified.

8 sept 2026, 19:41 UTC

Certara Inc is lower today, impacted by weakness in the Health Care Technology sub-sector. The stock remains below its 20-day moving average.

3 sept 2026, 20:07 UTC

Certara Inc shares are lower today, continuing a decline since Wednesday amid a broader downturn in the health care technology sector.

1 sept 2026, 20:08 UTC

Certara Inc shares are lower today, continuing a downward trend from earlier sessions and remaining below the 20-day moving average.

31 ago 2026, 22:02 UTC

Shares of Certara Inc. are trading lower during after-market hours, reversing a trend of higher daily closes. No specific news was identified.

27 ago 2026, 20:01 UTC

Certara Inc shares are higher today, continuing an upward trend since Wednesday. Broader market sentiment may be influenced by declining initial jobless claims.

26 ago 2026, 19:56 UTC

Shares of Certara Inc. are modestly higher today, reflecting typical intraday fluctuations. No specific company news was identified to explain the move.

25 ago 2026, 20:51 UTC

Certara Inc shares are higher in after-market trading, continuing a rise since Tuesday's close amid favorable market conditions and lower U.S. Treasury yields.

24 ago 2026, 20:01 UTC

Certara Inc shares are lower today, continuing a decline since Friday's close amid broader market pressures and geopolitical concerns affecting oil supply and inflation.

21 ago 2026, 19:56 UTC

Certara Inc shares are lower today, continuing a decline since Thursday. The stock is significantly below its 20-day moving average.

20 ago 2026, 20:06 UTC

Certara Inc shares are higher during Thursday's session, reflecting broader market dynamics and notable increases in U.S. Treasury yields and crude oil prices.

19 ago 2026, 23:56 UTC

Certara Inc. shares are lower in after-hours trading, showing slight declines since Wednesday's close while remaining above the 20-day moving average.

18 ago 2026, 19:36 UTC

Certara Inc. is trading higher during Tuesday's session, maintaining routine performance within a narrow range above its 20-day moving average.

13 ago 2026, 19:41 UTC

Certara Inc is rising, supported by strength in the Health Care Technology sub-sector, despite a slight pullback from earlier session highs.

12 ago 2026, 19:46 UTC

News

Certara shares are lower as Jefferies raises the price target to $7.45 from $6.00 while maintaining a Hold rating.

11 ago 2026, 23:51 UTC

Certara Inc is higher in after-hours trading, reflecting strong momentum and robust interest following notable activity earlier in the session.

7 ago 2026, 19:26 UTC

Certara Inc shares are higher today, maintaining a positive trajectory since Thursday. The stock remains above its 20-day moving average.

6 ago 2026, 20:02 UTC

News

Certara Inc is rising today, driven by strength in the Health Care Technology sub-sector. The stock remains above its 20-day moving average.

5 ago 2026, 20:13 UTC

Certara Inc shares are lower in after-market trading amid broader market fluctuations and rising gold prices, reflecting ongoing geopolitical tensions.

4 ago 2026, 20:03 UTC

News

Certara reported a second-quarter net loss of $6.1 million and lowered its full-year guidance, contributing to a decline in shares during today's session.

3 ago 2026, 19:26 UTC

News

Certara Inc shares are higher, supported by gains in the Health Care Technology sector. The company will report Q2 2026 results on August 4.

31 jul 2026, 19:26 UTC

Certara Inc shares are higher today, recovering from an early dip and trading near the top of their one-month range. No specific news was identified.

30 jul 2026, 19:58 UTC

Certara Inc is lower amid Health Care Technology sub-sector weakness. The stock reversed an early gain and remains above its 20-day moving average.

29 jul 2026, 18:53 UTC

Health Care Technology sector strength is lifting Certara Inc during Wednesday's session. The asset remains above its 20-day moving average, marking six straight days of gains.

Comparación entre iguales

Cambio de precio

Certara Inc previsión

Precio Objetivo

By TipRanks

-3.8% descenso

Estimación a 12 Meses

Media 8.1 USD  -3.8%

Máximo 9 USD

Mínimo 7 USD

De acuerdo con 7 analistas de Wall Street que ofrecen objetivos de precios a 12 meses para Certara Inc Dist en los últimos 3 meses.

Consenso

By TipRanks

Neutral

7 ratings

1

Comprar

6

Mantener

0

Vender

Sentimiento

By Acuity

106 / 339 Clasificación en Sanidad

Noticias sobre sentimiento de mercado

Neutral

Volatilidad

Por debajo de la media

Volumen de Noticias (RCV)

Por debajo de la media

Finanzas

Gastos de venta y administración

Gastos operativos

Beneficio antes de impuestos

Ventas

Coste de ventas

Beneficio bruto de ventas

Gasto por intereses de deuda

EBITDA

Beneficio operativo

$

Acerca de Certara Inc

Certara, Inc., together with its subsidiaries, provides software products and technology-enabled services to customers for biosimulation in drug discovery, preclinical and clinical research, regulatory submissions, and market access in the United States and internationally. It offers solutions for model-informed drug development, as well as biosimulation solution used to predict both pharmacokinetics and pharmacodynamics. The company provides Simcyp Simulator, a mechanistic biosimulation platform mechanistic biosimulation investigational new drug and translational stages; Simcyp Biopharmaceutics, used to identify and refine drug formulations; and Simcyp Secondary Intelligence which integrates toxicology with quantitative analysis of networks of molecular and functional biological changes to identify drug toxicity and adverse drug reactions. In addition, it offers Phoenix WinNonlin, a platform for non-compartmental analysis, pharmacokinetic/pharmacodynamic, and toxicokinetic; phoenix hosted, that provides a secured and validated certara amazon web services workspace; Phoenix NLME, a population modeling and simulation software for nonlinear mixed effects models; and pirana modeling workbench. Further, the company provides pinnacle 21, a cloud-based platform for clinical data automation, standardization, and validation; Pinnacle 21 Data Exchange, used to define data standards and specifications; and Metadata Repository, to enable study design using controlled and standardized data. It serves life sciences companies, biopharmaceutical companies, research organizations, academic institutions, and global regulators, as well as animal health, crop science, bio science, medical devices, and public sector industries. Certara Inc. was founded in 2008 and is headquartered in Princeton, New Jersey.